Filing Details
- Accession Number:
- 0001127602-14-000810
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-03 16:34:18
- Reporting Period:
- 2014-01-02
- Filing Date:
- 2014-01-03
- Accepted Time:
- 2014-01-03 16:34:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64803 | Cvs Caremark Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194413 | J Larry Merlo | One Cvs Drive Woonsocket RI 02895- | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-02 | 46,393 | $28.10 | 163,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-02 | 46,393 | $70.80 | 117,033 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-02 | 46,393 | $28.10 | 163,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-02 | 46,393 | $70.75 | 117,033 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-02 | 68,044 | $34.42 | 185,077 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-02 | 68,044 | $70.74 | 117,033 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-01-02 | 68,045 | $34.42 | 185,078 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-02 | 68,045 | $70.75 | 117,033 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2014-01-02 | 46,393 | $0.00 | 46,393 | $28.10 |
| Common Stock | Stock Option | Disposition | 2014-01-02 | 46,393 | $0.00 | 46,393 | $28.10 |
| Common Stock | Stock Option | Disposition | 2014-01-02 | 68,044 | $0.00 | 68,044 | $34.42 |
| Common Stock | Stock Option | Disposition | 2014-01-02 | 68,045 | $0.00 | 68,045 | $34.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 139,179 | 2010-04-01 | 2016-04-01 | No | 4 | M | Direct |
| 92,786 | 2010-04-01 | 2016-04-01 | No | 4 | M | Direct |
| 68,045 | 2008-04-02 | 2014-04-02 | No | 4 | M | Direct |
| 0 | 2008-04-02 | 2014-04-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 340,690 | Indirect | By Trust As Beneficiary |
| Common Stock (Restricted) | 264,753 | Direct | |
| Esop Common Stock | 6,365 | Indirect | By ESOP |
| Stock Unit | 408,649 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Phantom Stock Credits | $1.00 | 5,189 | 5,189 | Direct | ||
| Common Stock | Stock Option | $41.17 | 2009-04-01 | 2015-04-01 | 144,144 | 144,144 | Direct |
| Common Stock | Stock Option | $36.23 | 2011-04-01 | 2017-04-01 | 152,988 | 152,988 | Direct |
| Common Stock | Stock Option | $34.96 | 2012-04-01 | 2018-04-01 | 241,150 | 241,150 | Direct |
| Common Stock | Stock Option | $45.07 | 2013-04-02 | 2019-04-02 | 332,736 | 332,736 | Direct |
| Common Stock | Stock Option | $54.53 | 2014-04-01 | 2020-04-01 | 314,713 | 314,713 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 5,189 | 5,189 | Direct | |
| 2015-04-01 | 144,144 | 144,144 | Direct |
| 2017-04-01 | 152,988 | 152,988 | Direct |
| 2018-04-01 | 241,150 | 241,150 | Direct |
| 2019-04-02 | 332,736 | 332,736 | Direct |
| 2020-04-01 | 314,713 | 314,713 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.58 and $71.05 per share.
- Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.57 and $71.08 per share.
- Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.64 and $70.98 per share.
- Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.61 and $71.05 per share.
- Option became exercisable in three equal annual installments, commencing 4/1/2010.
- Option became exercisable in three equal annual installments, commencing 4/2/2008.
- Each share credit is equivalent to one share; 1-for-1 conversion.
- Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such timee as has been elected by the reporting person.
- Option became exercisable in three equal annual installments, commencing 4/1/2009.
- Option became exercisable in three equal annual installments, commencing 4/1/2011.
- Option became exercisable in four equal annual installments, commencing 4/1/2012.
- Option became exercisable in four equal annual installments, commencing 4/2/2013.
- Option becomes exercisable in four equal annual installments, commencing 4/1/2014.
Billionaire Hedge Funds
